BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24061474)

  • 1. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
    Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
    Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
    J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein S-glutathionylation stimulate adipogenesis by stabilizing C/EBPβ in 3T3L1 cells.
    Watanabe Y; Watanabe K; Fujioka D; Nakamura K; Nakamura T; Uematsu M; Bachschmid MM; Matsui R; Kugiyama K
    FASEB J; 2020 Apr; 34(4):5827-5837. PubMed ID: 32141127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
    Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
    Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.
    Lin HY; Liu YS; Huang CY; Cathomas F; Liu K; Wang J; Cheng HT; Lai SW; Liu YC; Chen CJ; Lin C; Lu DY
    Psychoneuroendocrinology; 2020 Oct; 120():104800. PubMed ID: 32688147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of adipogenesis by the SUMO-specific protease SENP2.
    Chung SS; Ahn BY; Kim M; Choi HH; Park HS; Kang S; Park SG; Kim YB; Cho YM; Lee HK; Chung CH; Park KS
    Mol Cell Biol; 2010 May; 30(9):2135-46. PubMed ID: 20194620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
    Leitao BB; Jones MC; Brosens JJ
    FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
    Sugiokto FG; Saiada F; Zhang K; Li R
    mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
    Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
    J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.
    Galanty Y; Belotserkovskaya R; Coates J; Polo S; Miller KM; Jackson SP
    Nature; 2009 Dec; 462(7275):935-9. PubMed ID: 20016603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theobromine suppresses adipogenesis through enhancement of CCAAT-enhancer-binding protein β degradation by adenosine receptor A1.
    Mitani T; Watanabe S; Yoshioka Y; Katayama S; Nakamura S; Ashida H
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2438-2448. PubMed ID: 28965824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
    Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
    Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
    Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
    Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3.
    Li R; Pan Y; Shi DD; Zhang Y; Zhang J
    Antiviral Res; 2013 Nov; 100(2):546-54. PubMed ID: 24036127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
    Han MM; Hirakawa M; Yamauchi M; Matsuda N
    Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.